发明名称 |
FORMULATIONS OF AZAINDOLE COMPOUNDS |
摘要 |
A pharmaceutical composition comprises: a) 5 wt % to 95 wt % of a HCl salt of Compound (1).xH2O by the weight of the pharmaceutical composition, wherein x is from 0 to 3; and b) 5 wt % to 95 wt % of a filler by the weight of the pharmaceutical composition. Another pharmaceutical composition comprises: a) 1 mg/mL to 20 mg/mL of Compound (1) in water; and b) 0.01 M to 0.1 M of a pharmaceutically acceptable pH modifier. A method of preparing a pharmaceutical composition, comprising providing a mixture of Compound (1) that includes the HCl salt of Compound (1).xH2O and the filler. Another method of preparing a pharmaceutical composition comprises mixing the HCl salt of Compound (1).xH2O and the pH modifier to form 1 mg/mL to 20 mg/mL of Compound (1) in water. Methods of reducing the amount of influenza viruses, inhibiting the replication of influenza viruses, and treating influenza each independently employ such pharmaceutical compositions. |
申请公布号 |
US2016250213(A1) |
申请公布日期 |
2016.09.01 |
申请号 |
US201615150497 |
申请日期 |
2016.05.10 |
申请人 |
Vertex Pharmaceuticals Incorporated |
发明人 |
Simone Eric Arthur;Sanghvi Tapan;Banda Alamelu;Stavropoulos Katherine |
分类号 |
A61K31/506;A61K31/4965;A61K31/16;A61K31/351;A61K9/20;A61K45/06 |
主分类号 |
A61K31/506 |
代理机构 |
|
代理人 |
|
主权项 |
1. A pharmaceutical composition comprising:
a) a HCl salt of Compound (1).xH2O wherein Compound (1) is represented by the following structural formula:wherein x is from 0 to 3; and
b) one or more excipients comprising a filler, a disintegrant agent, a wetting agent, a binder, a glidant, a lubricant, or any combination thereof, wherein the HCl salt of Compound (1).xH2O has a concentration of 5 wt % to 95 wt % by weight of the composition, and the one or more excipients has a concentration of 5 wt % to 95 wt % by weight of the composition. |
地址 |
Boston MA US |